logo
Select company
Select metric
$ 5.61MShareholders Equity
VS
Market
17
Sector
24
Industry
27
History
39
$ 4.15Close
$ 4.15 - $ 16.1 52-Week Range
Ticker Information

Ticker

DRMA

Company Name

DERMATA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DERMATA THERAPEUTICS INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DRMA - Equity Historical data
DateShareholders Equity
6/30/2025$ 5.61M
3/31/2025$ 7.3M
12/31/2024$ 1.56M
9/30/2024$ 4.74M
6/30/2024$ 3.32M
3/31/2024$ 3.81M
12/31/2023$ 6.36M
9/30/2023$ 6.41M
6/30/2023$ 8.03M
3/31/2023$ 8.09M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

DRMA - Shareholders Equity, Last 5 years

$ -3.18M

Minimum

Dec 31, 2020

$ 12.49M

Maximum

Sep 30, 2021

$ 5.57M

Average

$ 6.36M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 385.07M with a standard deviation of $ 549.23M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 385.07M
median$ 167.44M
std$ 549.23M